Assignee
NEOMATRIX THERAPEUTICS INC
US·2 granted patents·1 pending application·0 citations·filing 2017–2022
Top patents by PatentIndex Score
3 records- 0161US2023331814A1Peptides derived from fibronectin with improved bioactivity and reduced susceptibility to neutrophil elastase degradationNEOMATRIX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0244US11548935B2Peptides derived from fibronectin with improved bioactivity and reduced susceptibility to neutrophil elastase degradationNEOMATRIX THERAPEUTICS INC·Filed 2017·Granted Jan 10, 2023·0 cites·13 claims
- 0340US10729741B2Methods of treating burns with i.v. cP12 in a window from 2 to 6 hours after injuryNEOMATRIX THERAPEUTICS INC·Filed 2017·Granted Aug 4, 2020·0 cites·8 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →